The post Injective Revenue to FDV Ratio Tops Major Blockchains: Can INJ Benefit? appeared first on Coinpedia Fintech News
Injective is making a numbers driven pitch to crypto investors. Its revenue to fully dilution valuation (FDV) ratio now leads the major blockchain platforms shown in the year 2026 year to date comparison, putting INJ ahead of better known rivals on this particular metric. The catch? A strong ratio can support a valuation argument, but …
